Method of reducing bodyweight and treating obesity

• US 6,034,132 A
• Filed: 03/19/1998
• Issued: 03/07/2000
• Est. Priority Date: 01/05/1998
• Status: Expired due to Term

• Current Assignee: Aker BioMarine ASA
• Original Assignee: Natural Nutrition, Ltd. AS
• Inventors: Remmereit, Jan
• Primary Examiner(s): Spivack, Phyllis G.
• Application Number:
  US09/044,289
• Time in Patent Office: 719 Days
• Field of Search: 514/560
• US Class Current: 514/560
• CPC Class Codes: A61K 31/19 Carboxylic acids, e.g. valproic acid salicylic acid A61K31/60
• CPC Class Codes: A61P 3/04 Anorexiants; Antiobesity agents

Abstract

The present invention discloses method for reducing body weight and treating obesity. The method comprises administering a nutritionally effective amount of conjugated linoleic acid to a human. The conjugated linoleic acid may be provided in the form of a free fatty acid in a pill, or as a component of a prepared food product.

Claims

1. A method of reducing weight in humans, said method comprising orally administering a nutritionally effective amount of conjugated linoleic acid.

3. The methods of claims 1 or 2, wherein said nutritionally effective and said therapeutically effective amounts of conjugated linoleic acid are about 0.1 to 15 grams per day.

4. The methods of claims 1 or 2 wherein said conjugated linoleic acid is a mixture of octadecadienoic acid isomers selected from the group of cis-9, trans-11;

cis-9, cis-11;

trans-9, cis-11;

trans-9, trans-11;

cis-10, cis-12;

cis-10, trans-12, trans-10, cis-12; and

trans-10, trans-12 octadecadienoic acid.

5. The methods of claims 1 or 2 wherein said nutritionally and therapeutically effective amounts of conjugated linoleic acid are provided in a prepared food product.

6. The methods of claims 1 or 2 wherein the conjugated linoleic acid is cis-9, trans-11 octadecadienoic acid.

2. A method for treating obesity in humans, said method comprising orally administering a therapeutically effective amount of conjugated linoleic acid, said therapeutic amount sufficient to reduce bodyweight.

7. A method of reducing weight in humans, said method comprising orally administering about 1 to 5 grams per day of a mixture of octadecadienoic acids selected from the group consisting of cis-9, trans-11;

cis-9, cis-11;

trans-9, cis-11;

trans-9, trans-11;

cis-10, cis-12;

cis-10, trans-12;

trans-10, cis-12; and

trans-10, trans-12 octadecadienoic acids.

8. A method of treating obesity in humans, said method comprising orally administering about 1 to 5 grams per day of a mixture of octadecadienoic acids selected from the group consisting of cis-9, trans-11;

cis-9, cis-11;

trans-9, cis-11;

trans-9, trans-11;

cis-10, cis-12;

cis-10, trans-12;

trans-10, cis-12; and

trans-10, trans-12 octadecadienoic acids, so that bodyweight is reduced.